Prognosis
EU Speeds Up J&J Vaccine Review, Sees Recommendation Next Week
This article is for subscribers only.
The European Union’s drug regulator is accelerating its review of blood-clot reports with Johnson & Johnson’s Covid-19 vaccine and said it expects to issue a recommendation next week.
EU member states should store doses as they await guidance, and the European Medicines Agency said in an emailed statement it will decide shortly whether “regulatory action is necessary.”